Literature DB >> 35362928

Response-An Extreme Ordeal: Writing Emotion in Qualitative Research.

Siun Gallagher1.   

Abstract

Responding to the stimulus afforded by Little et al.'s "Pragmatic pluralism: Mutual tolerance of contested understandings between orthodox and alternative practitioners in autologous stem cell transplantation," this paper explores how the norms of qualitative inquiry affect the representation of emotion in research reports. It describes a conflict between the construction of emotion in qualitative research accounts and its application to analysis and theorization, whose origins may lie in researchers' reticence when it comes to conveying or using the emotional features of data. The technical aspects of report writing that are associated with this conflict are explored via a deconstruction of Little et al.'s paper and a survey of the qualitative research methods literature. Writing to convey emotion and analysing to include author-constructed emotional context are neglected topics. Using data in Little et al.'s text, the paper demonstrates the importance of author-constructed emotional context to theory generation. The paper recommends the inclusion of emotional context as data in analysis and points to lessons Little et al.'s paper offers in the areas of narrative technique and reflexive practice.
© 2022. Journal of Bioethical Inquiry Pty Ltd.

Entities:  

Keywords:  Cancer; Communicative alienation; Complementary and alternative medicine; Empathy; Qualitative methods

Mesh:

Year:  2022        PMID: 35362928     DOI: 10.1007/s11673-021-10151-x

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  2 in total

1.  A Discursive Exploration of Values and Ethics in Medicine: The Scholarship of Miles Little.

Authors:  Claire Hooker; Ian Kerridge; Kathryn Mackay; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2022-03       Impact factor: 2.216

2.  Liminality: The Not-So-New Normal?

Authors:  Michael A Ashby
Journal:  J Bioeth Inq       Date:  2022-03       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.